{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:28:10Z","timestamp":1790962090716,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00392-016-0999-4","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T07:16:25Z","timestamp":1464678985000},"page":"912-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study"],"prefix":"10.1007","volume":"105","author":[{"name":"On behalf of REPOSI investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Napoleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Mannuccio","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"999_CR1","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","volume":"133","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS et al (2015) Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation 133:e38\u2013e360. doi: 10.1161\/CIR.0000000000000350","journal-title":"Circulation"},{"key":"999_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370\u20132375. doi: 10.1001\/jama.285.18.2370","journal-title":"JAMA"},{"key":"999_CR3","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GYH, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719\u20132747. doi: 10.1093\/eurheartj\/ehs253","journal-title":"Eur Heart J"},{"key":"999_CR4","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1001\/jama.2015.4369","volume":"313","author":"GYH Lip","year":"2015","unstructured":"Lip GYH, Lane DA (2015) Stroke prevention in atrial fibrillation. JAMA 313:1950\u20131962. doi: 10.1001\/jama.2015.4369","journal-title":"JAMA"},{"key":"999_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/europace\/euv304","volume":"18","author":"P Kirchhof","year":"2015","unstructured":"Kirchhof P, Breithardt G, Bax J et al. (2015) A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network\/European Heart Rhythm Association consensus conference. Europace 18:37\u201350. doi: 10.1093\/europace\/euv304","journal-title":"Europace"},{"key":"999_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","volume":"1","author":"Y Wan","year":"2008","unstructured":"Wan Y, Heneghan C, Perera R et al (2008) Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 1:84\u201391. doi: 10.1161\/CIRCOUTCOMES.108.796185","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"999_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1160\/TH11-05-0353","volume":"106","author":"AM Gallagher","year":"2011","unstructured":"Gallagher AM, Setakis E, Plumb JM et al (2011) Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost 106:968\u2013977. doi: 10.1160\/TH11-05-0353","journal-title":"Thromb Haemost"},{"key":"999_CR8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1160\/TH13-06-0443","volume":"110","author":"R Caterina De","year":"2013","unstructured":"De Caterina R, Husted S, Wallentin L et al (2013) Vitamin K antagonists in heart disease: current status and perspectives (Section III). Thromb Haemost 110:1087\u20131107. doi: 10.1160\/TH13-06-0443","journal-title":"Thromb Haemost"},{"key":"999_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/ageing\/afr097","volume":"40","author":"D Pugh","year":"2011","unstructured":"Pugh D, Pugh J, Mead GE (2011) Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 40:675\u2013683. doi: 10.1093\/ageing\/afr097","journal-title":"Age Ageing"},{"key":"999_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv269","author":"GYH Lip","year":"2015","unstructured":"Lip GYH, Laroche C, Popescu MI et al (2015) Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Europace. doi: 10.1093\/europace\/euv269","journal-title":"Europace"},{"key":"999_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","volume":"56","author":"R Marinigh","year":"2010","unstructured":"Marinigh R, Lip GYH, Fiotti N et al (2010) Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol 56:827\u2013837. doi: 10.1016\/j.jacc.2010.05.028","journal-title":"J Am Coll Cardiol"},{"key":"999_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/STROKEAHA.114.007199","volume":"46","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Clementy N, Pericart L et al (2014) Stroke and major bleeding risk in elderly patients aged \u226575\u00a0years with atrial fibrillation: the Loire Valley atrial fibrillation project. Stroke 46:143\u2013150. doi: 10.1161\/STROKEAHA.114.007199","journal-title":"Stroke"},{"key":"999_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00228-010-0977-0","volume":"67","author":"A Nobili","year":"2011","unstructured":"Nobili A, Licata G, Salerno F et al (2011) Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 67:507\u2013519. doi: 10.1007\/s00228-010-0977-0","journal-title":"Eur J Clin Pharmacol"},{"key":"999_CR14","volume-title":"A manual of guidelines for scoring the cumulative illness rating scale for geriatrics (CIRS-G)","author":"MD Miller","year":"1991","unstructured":"Miller MD, Towers A (1991) A manual of guidelines for scoring the cumulative illness rating scale for geriatrics (CIRS-G). University of Pittsburg, Pittsburg, PA"},{"key":"999_CR15","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/j.1532-5415.2008.01935.x","volume":"56","author":"F Salvi","year":"2008","unstructured":"Salvi F, Miller MD, Grilli A et al (2008) A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc 56:1926\u20131931. doi: 10.1111\/j.1532-5415.2008.01935.x","journal-title":"J Am Geriatr Soc"},{"key":"999_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1176\/ajp.140.6.734","volume":"140","author":"R Katzman","year":"1983","unstructured":"Katzman R, Brown T, Fuld P et al (1983) Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 140:734\u2013739. doi: 10.1176\/ajp.140.6.734","journal-title":"Am J Psychiatry"},{"key":"999_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37\u201349","journal-title":"J Psychiatr Res"},{"key":"999_CR18","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) Functional evaluation: the barthel index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"999_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","volume":"153","author":"R Nieuwlaat","year":"2007","unstructured":"Nieuwlaat R, Olsson SB, Lip GYH et al (2007) Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J 153:1006\u20131012. doi: 10.1016\/j.ahj.2007.03.008","journal-title":"Am Heart J"},{"key":"999_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11739-014-1096-1","volume":"9","author":"V Raparelli","year":"2014","unstructured":"Raparelli V, Proietti M, Butt\u00e0 C et al (2014) Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med 9:861\u2013870. doi: 10.1007\/s11739-014-1096-1","journal-title":"Intern Emerg Med"},{"key":"999_CR21","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.ijcard.2012.07.019","volume":"167","author":"G Pasquale Di","year":"2013","unstructured":"Di Pasquale G, Mathieu G, Pietro Maggioni A et al (2013) Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study. Int J Cardiol 167:2895\u20132903. doi: 10.1016\/j.ijcard.2012.07.019","journal-title":"Int J Cardiol"},{"key":"999_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ejim.2010.07.014","volume":"21","author":"M Marcucci","year":"2010","unstructured":"Marcucci M, Iorio A, Nobili A et al (2010) Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Intern Med 21:516\u2013523. doi: 10.1016\/j.ejim.2010.07.014","journal-title":"Eur J Intern Med"},{"key":"999_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejim.2013.04.008","volume":"24","author":"G Gussoni","year":"2013","unstructured":"Gussoni G, Di Pasquale G, Vescovo G et al (2013) Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study. Eur J Intern Med 24:324\u2013332. doi: 10.1016\/j.ejim.2013.04.008","journal-title":"Eur J Intern Med"},{"key":"999_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2459\/JCM.0b013e328348e5ce","volume":"14","author":"M Campanini","year":"2013","unstructured":"Campanini M, Frediani R, Artom A et al (2013) Real-world management of atrial fibrillation in Internal Medicine units: the FADOI \u201cFALP\u201d observational study. J Cardiovasc Med (Hagerstown) 14:26\u201334. doi: 10.2459\/JCM.0b013e328348e5ce","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"999_CR25","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1093\/eurheartj\/ehv304","volume":"36","author":"F Andreotti","year":"2015","unstructured":"Andreotti F, Rocca B, Husted S et al (2015) Antithrombotic therapy in the elderly: expert position paper of the European society of cardiology working group on thrombosis. Eur Heart J 36:3238\u20133249. doi: 10.1093\/eurheartj\/ehv304","journal-title":"Eur Heart J"},{"key":"999_CR26","doi-asserted-by":"publisher","first-page":"20432","DOI":"10.1038\/srep20432","volume":"6","author":"TS Potpara","year":"2016","unstructured":"Potpara TS, Dan G-A, Trendafilova E et al (2016) Stroke prevention in atrial fibrillation and \u201creal world\u201d adherence to guidelines in the Balkan Region: the BALKAN-AF Survey. Sci Rep 6:20432. doi: 10.1038\/srep20432","journal-title":"Sci Rep"},{"issue":"601\u2013609","key":"999_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ahj.2013.12.014","volume":"167","author":"EC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien EC, Holmes DN, Ansell JE et al (2014) Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J 167(601\u2013609):e1. doi: 10.1016\/j.ahj.2013.12.014","journal-title":"Am Heart J"},{"key":"999_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cjca.2015.05.012","volume":"32","author":"MCD Lefebvre","year":"2015","unstructured":"Lefebvre MCD, St-Onge M, Glazer-Cavanagh M et al (2015) The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study. Can J Cardiol 32:169\u2013176. doi: 10.1016\/j.cjca.2015.05.012","journal-title":"Can J Cardiol"},{"key":"999_CR29","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GYH et al (2010) Guidelines for the management of atrial fibrillation. Eur Heart J 31:2369\u20132429. doi: 10.1093\/eurheartj\/ehq278","journal-title":"Eur Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-0999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-016-0999-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-0999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:23:56Z","timestamp":1498303436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-016-0999-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s00392-016-0999-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}